⌘K

Login Start Free

Home/Filings/4/0001493152-22-016401

4//SEC Filing

Fink Jeffrey Arvin 4

Accession 0001493152-22-016401

CIK 0001535955other

View on SEC.gov Company Profile

Filed

Jun 9, 8:00 PM ET

Accepted

Jun 10, 11:33 AM ET

Size

5.1 KB

Accession

0001493152-22-016401

Insider Transaction Report

Form 4

Period: 2022-06-08

Lipocine Inc.LPCN

Fink Jeffrey Arvin

Director

Transactions

Award
Common Stock (Right to Buy)
2022-06-08$0.92/sh+22,000$20,240→ 136,000 total
Exercise: $0.92From: 2023-06-08Exp: 2032-06-08→ Common Stock (22,000 underlying)

Documents

1 file

4
ownership.xmlPrimary

Issuer

Lipocine Inc.

CIK 0001535955

Entity typeother

Related Parties

1

filerCIK 0001595930

Filing Metadata

Form type: 4
Filed: Jun 9, 8:00 PM ET
Accepted: Jun 10, 11:33 AM ET
Size: 5.1 KB

View on SEC.gov